๐ŸŒ cemdisiran

organization

Cemdisiran is an investigational RNA interference therapy developed by Alnylam Pharmaceuticals to reduce complement component C5 production for potential treatment of complement-mediated diseases.

1
Signals
1
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
Seven-minute virtual reality intervention helps students tackle stress and exam anxiety expired Health involved 100%